Technical Analysis for XAIR - Beyond Air, Inc.

Grade Last Price % Change Price Change
C 0.49 -14.00% -0.08
XAIR closed down 14.0 percent on Friday, November 1, 2024, on 1.33 times normal volume.
Earnings due: Nov 11
*** please verify all earnings dates ***
1 Watcher
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Down Up Up

Date Alert Name Type % Chg
Bearish Engulfing Bearish 0.00%
Upper Bollinger Band Walk Strength 0.00%
Outside Day Range Expansion 0.00%
Wide Bands Range Expansion 0.00%
Overbought Stochastic Strength 0.00%
Upper Bollinger Band Touch Strength 0.00%
Pocket Pivot Bullish Swing Setup -14.00%
Calm After Storm Range Contraction -14.00%
Stochastic Reached Overbought Strength -14.00%
Upper Bollinger Band Walk Strength -14.00%

   Recent Intraday Alerts

Alert Time
Outside Day about 19 hours ago
Fell Below Previous Day's Low about 19 hours ago
Down 10% about 19 hours ago
Down 1 ATR about 19 hours ago
Rose Above Previous Day's High about 22 hours ago

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Beyond Air, Inc. Description

Beyond Air, Inc. is a clinical-stage medical device and biopharmaceutical company developing a revolutionary NO Generator and Delivery System that uses NO generated from ambient air and delivers precise amounts of NO to the lungs for the potential treatment of respiratory and other diseases. The Beyond Air NO Delivery System can generate up to 400 ppm of NO for delivery either continuously or for a fixed amount of time and has the ability to either titrate dose on demand or maintain a constant dose. The Company is currently applying its therapeutic expertise to develop treatments for pulmonary hypertension in various settings, in addition to treatments for lower respiratory tract infections that are not effectively addressed with current standards of care. Beyond Air is currently advancing its revolutionary NO Generator and Delivery System in clinical trials for the treatment of bronchiolitis and severe lung infections such as nontuberculous mycobacteria (NTM).


Classification

Sector: Industrials
Industry: Conglomerates
Keywords: Medicine Biopharmaceutical Hypertension Coronavirus Pulmonary Hypertension Tuberculosis Bacterial Disease Bacteriology Lung Infection Nontuberculous Mycobacteria Lower Respiratory Tract Infection Lung Infections Mycobacterium Respiratory And Other Diseases Respiratory Tract Respiratory Tract Infection

Is XAIR a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 2.4027
52 Week Low 0.296
Average Volume 589,048
200-Day Moving Average 1.02
50-Day Moving Average 0.40
20-Day Moving Average 0.39
10-Day Moving Average 0.44
Average True Range 0.06
RSI (14) 59.51
ADX 24.52
+DI 31.76
-DI 13.92
Chandelier Exit (Long, 3 ATRs) 0.42
Chandelier Exit (Short, 3 ATRs) 0.47
Upper Bollinger Bands 0.53
Lower Bollinger Band 0.26
Percent B (%b) 0.86
BandWidth 69.71
MACD Line 0.03
MACD Signal Line 0.01
MACD Histogram 0.0216
Fundamentals Value
Market Cap 17.45 Million
Num Shares 35.6 Million
EPS -2.05
Price-to-Earnings (P/E) Ratio -0.24
Price-to-Sales 223.45
Price-to-Book 2.60
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 0.66
Resistance 3 (R3) 0.67 0.63 0.63
Resistance 2 (R2) 0.63 0.59 0.62 0.62
Resistance 1 (R1) 0.56 0.56 0.54 0.55 0.61
Pivot Point 0.52 0.52 0.51 0.51 0.52
Support 1 (S1) 0.45 0.48 0.43 0.43 0.37
Support 2 (S2) 0.41 0.45 0.40 0.36
Support 3 (S3) 0.34 0.41 0.35
Support 4 (S4) 0.32